Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Antipyrine | hsa00010 | Glycolysis / Gluconeogenesis | 3.34E-03 | 4 | P04075, P04406, P60174, P06744 | ALDOA, GAPDH, TPI1, GPI | More | | Antipyrine | hsa00030 | Pentose phosphate pathway | 4.19E-02 | 2 | P06744, P04075 | GPI, ALDOA | More | | Antipyrine | hsa00051 | Fructose and mannose metabolism | 2.90E-02 | 2 | P60174, P04075 | TPI1, ALDOA | More | | Antipyrine | hsa00052 | Galactose metabolism | 4.27E-02 | 2 | P06280, O43451 | GLA, MGAM | More | | Antipyrine | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | | Antipyrine | hsa00250 | Alanine, aspartate and glutamate metabolism | 1.22E-02 | 2 | Q96RQ9, P15104 | IL4I1, GLUL | More | | Antipyrine | hsa00270 | Cysteine and methionine metabolism | 3.39E-02 | 2 | Q96RQ9, P40926 | IL4I1, MDH2 | More | | Antipyrine | hsa00500 | Starch and sucrose metabolism | 8.96E-06 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Antipyrine | hsa00512 | Mucin type O-glycan biosynthesis | 3.78E-02 | 2 | O95395, Q8N4A0 | GCNT3, GALNT4 | More | | Antipyrine | hsa00520 | Amino sugar and nucleotide sugar metabolism | 2.24E-02 | 3 | Q16222, Q9Y223, P06865 | UAP1, GNE, HEXA | More | | Antipyrine | hsa00561 | Glycerolipid metabolism | 1.12E-02 | 3 | Q8NEB5, P14550, Q86XP1 | PPAPDC1B, AKR1A1, DGKH | More | | Antipyrine | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | | Antipyrine | hsa00670 | One carbon pool by folate | 1.33E-02 | 2 | P04818, Q99707 | TYMS, MTR | More | | Antipyrine | hsa00730 | Thiamine metabolism | 1.44E-03 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Antipyrine | hsa00750 | Vitamin B6 metabolism | 3.56E-02 | 1 | O00764 | PDXK | More | | Antipyrine | hsa00830 | Retinol metabolism | 1.36E-03 | 1 | P00325 | ADH1B | More | | Antipyrine | hsa00900 | Terpenoid backbone biosynthesis | 1.22E-02 | 2 | P49354, Q9UHG3 | FNTA, PCYOX1 | More | | Antipyrine | hsa00970 | Aminoacyl-tRNA biosynthesis | 2.41E-05 | 4 | O95363, P54136, P14868, Q15046 | FARS2, RARS1, DARS, KARS | More | | Antipyrine | hsa01200 | Carbon metabolism | 1.61E-02 | 4 | P04075, P04406, P06744, P60174 | ALDOA, GAPDH, GPI, TPI1 | More | | Antipyrine | hsa01210 | 2-Oxocarboxylic acid metabolism | 3.56E-02 | 1 | P50213 | IDH3A | More | | Antipyrine | hsa01230 | Biosynthesis of amino acids | 1.60E-02 | 3 | P60174, P04406, P04075 | TPI1, GAPDH, ALDOA | More | | Antipyrine | hsa01524 | Platinum drug resistance | 4.78E-02 | 1 | P31751 | AKT2 | More | | Antipyrine | hsa02010 | ABC transporters | 4.93E-02 | 1 | Q8IZY2 | ABCA7 | More | | Antipyrine | hsa03008 | Ribosome biogenesis in eukaryotes | 2.99E-02 | 2 | P78345, Q9BVP2 | RPP38, GNL3 | More | | Antipyrine | hsa03013 | RNA transport | 4.92E-03 | 10 | P52298, Q09161, O14893, P61326, Q7Z3B4, P35658, Q14152, O75822, P78345, Q9Y6A5 | NCBP2, NCBP1, GEMIN2, MAGOH, NUP54, NUP214, EIF3A, EIF3J, RPP38, TACC3 | More | | Antipyrine | hsa03015 | mRNA surveillance pathway | 1.83E-02 | 3 | Q13362, Q14738, Q9UBU9 | PPP2R5C, PPP2R5D, NXF1 | More | | Antipyrine | hsa03020 | RNA polymerase | 5.03E-06 | 4 | P24928, P62487, Q9GZM3, P52435 | POLR2A, POLR2G, POLR2J2, POLR2J | More | | Antipyrine | hsa03040 | Spliceosome | 1.28E-05 | 13 | O43143, O60508, P08579, P26368, Q13595, Q07955, Q01130, P84103, Q13243, P11142, Q9Y2W2, O43447, O75643 | DHX15, CDC40, SNRPB2, U2AF2, TRA2A, SFRS1, SFRS2, SFRS3, SFRS5, HSPA8, WBP11, PPIH, ASCC3L1 | More | | Antipyrine | hsa03050 | Proteasome | 1.53E-03 | 1 | P55036 | PSMD4 | More | | Antipyrine | hsa03410 | Base excision repair | 2.90E-02 | 2 | P49005, P29372 | POLD2, MPG | More | | Antipyrine | hsa03450 | Non-homologous end-joining | 4.21E-02 | 1 | P13010 | XRCC5 | More | | Antipyrine | hsa04012 | ErbB signaling pathway | 1.91E-02 | 3 | P16333, P19174, P01106 | NCK1, PLCG1, MYC | More | | Antipyrine | hsa04014 | Ras signaling pathway | 4.37E-03 | 10 | P31751, P42338, P20827, P49767, Q13009, Q7LDG7, P0DP23, P63218, P50151, P19174 | AKT2, PIK3CB, EFNA1, VEGFC, TIAM1, RASGRP2, CALM1, GNG5, GNG10, PLCG1 | More | | Antipyrine | hsa04015 | Rap1 signaling pathway | 2.75E-03 | 10 | P20827, P49767, Q96FS4, P11215, Q13009, Q7LDG7, P42338, P31751, P0DP23, P19174 | EFNA1, VEGFC, SIPA1, ITGAM, TIAM1, RASGRP2, PIK3CB, AKT2, CALM1, PLCG1 | More | | Antipyrine | hsa04020 | Calcium signaling pathway | 2.41E-02 | 5 | Q96DU7, Q13557, P21860, P26678, P63092 | ITPKC, CAMK2D, ERBB3, PLN, GNAS | More | | Antipyrine | hsa04022 | cGMP-PKG signaling pathway | 5.07E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | | Antipyrine | hsa04024 | cAMP signaling pathway | 3.23E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | | Antipyrine | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 2.91E-02 | 6 | P09341, P25024, P25025, P47992, Q9UBD3, P01375 | CXCL1, CXCR1, CXCR2, XCL1, XCL2, TNF | More | | Antipyrine | hsa04062 | Chemokine signaling pathway | 9.23E-03 | 10 | P09769, P07948, P42338, P19174, P63218, P50151, P43250, Q7LDG7, Q13009, Q8WYR1 | FGR, LYN, PIK3CB, PLCG1, GNG5, GNG10, GRK6, RASGRP2, TIAM1, PIK3R5 | More | | Antipyrine | hsa04064 | NF-kappa B signaling pathway | 1.91E-04 | 12 | P10415, Q13489, P25963, P51617, O00463, P01375, Q04759, Q9UDY8, Q13077, Q16548, Q13315, P24522 | BCL2, BIRC3, NFKBIA, IRAK1, TRAF5, TNF, PRKCQ, MALT1, TRAF1, BCL2A1, ATM, GADD45A | More | | Antipyrine | hsa04071 | Sphingolipid signaling pathway | 5.94E-04 | 8 | P17252, P21453, Q9H228, P01375, Q13362, Q9BX95, Q16539, P10415 | PRKCA, S1PR1, EDG8, TNF, PPP2R5C, SGPP1, MAPK14, BCL2 | More | | Antipyrine | hsa04080 | Neuroactive ligand-receptor interaction | 3.11E-04 | 10 | P08311, Q15722, P21453, Q9H228, P43657, O00398, P21462, P21730, P14416, P35318 | CTSG, LTB4R, S1PR1, EDG8, P2RY5, P2RY10, FPR1, C5AR1, DRD2, ADM | More | | Antipyrine | hsa04110 | Cell cycle | 2.06E-02 | 6 | Q9UBD5, P06493, Q14683, P30304, P33981, P01106 | ORC3, CDK1, SMC1A, CDC25A, TTK, MYC | More | | Antipyrine | hsa04114 | Oocyte meiosis | 1.25E-03 | 7 | P51812, Q02750, P0DP23, P16298, Q17RY0, Q13362, Q14738 | RPS6KA3, MAP2K1, CALM1, PPP3CB, CPEB4, PPP2R5C, PPP2R5D | More | | Antipyrine | hsa04115 | p53 signaling pathway | 3.57E-02 | 5 | P24522, Q13315, Q53FA7, O95067, P10415 | GADD45A, ATM, TP53I3, CCNB2, BCL2 | More | | Antipyrine | hsa04145 | Phagosome | 3.63E-03 | 12 | Q15080, P14598, Q71U36, Q13509, Q13885, Q13488, P05164, O60603, P35443, P13765, P01889, P10321 | NCF4, NCF1, TUBA1A, TUBB3, TUBB2A, TCIRG1, MPO, TLR2, THBS4, HLA-DOB, HLA-B, HLA-C | More | | Antipyrine | hsa04146 | Peroxisome | 2.42E-02 | 5 | O43933, P56589, Q9UKG9, O75521, P33121 | PEX1, PEX3, CROT, ECI2, ACSL1 | More | | Antipyrine | hsa04150 | mTOR signaling pathway | 3.60E-02 | 3 | Q02750, Q9NQL2, P51812 | MAP2K1, RRAGD, RPS6KA3 | More | | Antipyrine | hsa04151 | PI3K-Akt signaling pathway | 3.70E-02 | 12 | P42338, P43657, P20827, P49767, P08238, Q8WYR1, P63218, P50151, O15335, Q13751, P14784, P30281 | PIK3CB, P2RY5, EFNA1, VEGFC, HSP90AB1, PIK3R5, GNG5, GNG10, CHAD, LAMB3, IL2RB, CCND3 | More | | Antipyrine | hsa04152 | AMPK signaling pathway | 1.83E-02 | 3 | Q96RR4, Q13362, Q14738 | CAMKK2, PPP2R5C, PPP2R5D | More | | Antipyrine | hsa04210 | Apoptosis | 1.52E-02 | 9 | Q13315, P10415, Q13489, P25963, P01375, P24522, Q16548, Q13077, Q14643 | ATM, BCL2, BIRC3, NFKBIA, TNF, GADD45A, BCL2A1, TRAF1, ITPR1 | More | | Antipyrine | hsa04218 | Cellular senescence | 5.03E-04 | 6 | P31751, P0DP23, P01889, P10321, P05141, P12236 | AKT2, CALM1, HLA-B, HLA-C, SLC25A5, SLC25A6 | More | | Antipyrine | hsa04261 | Adrenergic signaling in cardiomyocytes | 1.74E-03 | 4 | P31751, Q13362, Q14738, P0DP23 | AKT2, PPP2R5C, PPP2R5D, CALM1 | More | | Antipyrine | hsa04330 | Notch signaling pathway | 1.12E-02 | 3 | Q92542, P49768, P46531 | NCSTN, PSEN1, NOTCH1 | More | | Antipyrine | hsa04360 | Axon guidance | 2.88E-03 | 8 | P16333, P20827, O95631, P42338, P07332, P23528, P19174, Q06124 | NCK1, EFNA1, NTN1, PIK3CB, FES, CFL1, PLCG1, PTPN11 | More | | Antipyrine | hsa04370 | VEGF signaling pathway | 3.03E-04 | 4 | P16298, P31751, Q05397, Q02750 | PPP3CB, AKT2, PTK2, MAP2K1 | More | | Antipyrine | hsa04371 | Apelin signaling pathway | 9.78E-04 | 9 | P63218, P50151, Q8WYR1, P31751, Q14814, Q14344, Q13485, P84022, P0DP23 | GNG5, GNG10, PIK3R5, AKT2, MEF2D, GNA13, SMAD4, SMAD3, CALM1 | More | | Antipyrine | hsa04380 | Osteoclast differentiation | 2.72E-04 | 8 | Q9NQC7, Q9UQC2, Q16539, P31751, P14778, O75015, P01375, Q8N149 | CYLD, GAB2, MAPK14, AKT2, IL1R1, FCGR3B, TNF, LILRA2 | More | | Antipyrine | hsa04390 | Hippo signaling pathway | 2.30E-02 | 3 | P63261, P04628, O43623 | ACTG1, WNT1, SNAI2 | More | | Antipyrine | hsa04550 | Signaling pathways regulating pluripotency of stem cells | 1.96E-02 | 3 | P04628, P40189, P14653 | WNT1, IL6ST, HOXB1 | More | | Antipyrine | hsa04610 | Complement and coagulation cascades | 1.29E-05 | 2 | P00734, P0C0L4 | F2, C4A | More | | Antipyrine | hsa04612 | Antigen processing and presentation | 1.03E-02 | 7 | P48382, P26715, P26717, Q13241, O43908, P01732, P01375 | RFX5, KLRC1, KLRC2, KLRD1, KLRC4, CD8A, TNF | More | | Antipyrine | hsa04613 | Neutrophil extracellular trap formation | 1.28E-06 | 17 | P17252, O60603, P05164, P08246, Q9UM07, Q13547, Q6FI13, P14598, Q15080, P20160, P08311, P49913, O75015, P21730, P21462, O43315, Q16539 | PRKCA, TLR2, MPO, ELA2, PADI4, HDAC1, H2AC18; H2AC19, NCF1, NCF4, AZU1, CTSG, CAMP, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | | Antipyrine | hsa04620 | Toll-like receptor signaling pathway | 4.78E-02 | 1 | P31751 | AKT2 | More | | Antipyrine | hsa04621 | NOD-like receptor signaling pathway | 3.10E-03 | 11 | Q14643, P25963, Q13489, Q9H1Y0, P43490, O00463, P10415, Q05823, P01375, P49913, P12838 | ITPR1, NFKBIA, BIRC3, ATG5, PBEF1, TRAF5, BCL2, RNASEL, TNF, CAMP, DEFA4 | More | | Antipyrine | hsa04622 | RIG-I-like receptor signaling pathway | 3.02E-03 | 3 | Q9NQC7, Q12933, P10145 | CYLD, TRAF2, IL8 | More | | Antipyrine | hsa04625 | C-type lectin receptor signaling pathway | 2.27E-04 | 7 | Q9ULY5, Q9NQC7, P20749, P01375, P31751, P0DP23, Q16539 | CLEC4E, CYLD, BCL3, TNF, AKT2, CALM1, MAPK14 | More | | Antipyrine | hsa04630 | JAK-STAT signaling pathway | 4.43E-02 | 3 | P48551, P40189, Q06124 | IFNAR2, IL6ST, PTPN11 | More | | Antipyrine | hsa04650 | Natural killer cell mediated cytotoxicity | 6.72E-06 | 16 | P16298, P50591, P01375, P78314, P06239, O60880, P20963, Q29983, P10321, P01889, Q02750, Q13241, P26718, O75015, P26717, P26715 | PPP3CB, TNFSF10, TNF, SH3BP2, LCK, SH2D1A, CD247, MICA, HLA-C, HLA-B, MAP2K1, KLRD1, KLRK1, FCGR3B, KLRC2, KLRC1 | More | | Antipyrine | hsa04657 | IL-17 signaling pathway | 1.63E-04 | 8 | O00463, Q16539, P49841, P09341, P14780, Q9UJX4, P80188, P01375 | TRAF5, MAPK14, GSK3B, CXCL1, MMP9, ANAPC5, LCN2, TNF | More | | Antipyrine | hsa04658 | Th1 and Th2 cell differentiation | 9.73E-03 | 6 | P20963, P09693, Q16539, P06239, Q9UL17, P13765 | CD247, CD3G, MAPK14, LCK, TBX21, HLA-DOB | More | | Antipyrine | hsa04659 | Th17 cell differentiation | 4.08E-04 | 13 | Q16539, P19174, P06239, P14784, P13765, P14778, Q9UL17, P84022, Q13485, P08238, P07766, P09693, P20963 | MAPK14, PLCG1, LCK, IL2RB, HLA-DOB, IL1R1, TBX21, SMAD3, SMAD4, HSP90AB1, CD3E, CD3G, CD247 | More | | Antipyrine | hsa04660 | T cell receptor signaling pathway | 4.20E-02 | 7 | P01375, P25963, Q9UDY8, Q04759, P10747, O95267, Q08881 | TNF, NFKBIA, MALT1, PRKCQ, CD28, RASGRP1, ITK | More | | Antipyrine | hsa04662 | B cell receptor signaling pathway | 3.64E-03 | 6 | P31751, P42338, P60033, P07948, P21854, Q8N149 | AKT2, PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Antipyrine | hsa04664 | Fc epsilon RI signaling pathway | 7.42E-04 | 8 | P01375, P31751, Q16539, P42338, Q9UQC2, P07948, P19174, P09917 | TNF, AKT2, MAPK14, PIK3CB, GAB2, LYN, PLCG1, ALOX5 | More | | Antipyrine | hsa04668 | TNF signaling pathway | 1.83E-03 | 8 | P01375, O00463, Q13489, Q16539, P25963, P20749, Q13077, P14780 | TNF, TRAF5, BIRC3, MAPK14, NFKBIA, BCL3, TRAF1, MMP9 | More | | Antipyrine | hsa04670 | Leukocyte transendothelial migration | 4.20E-02 | 7 | P14780, Q96A32, P17252, P14598, Q15080, Q08881, P42681 | MMP9, MYLPF, PRKCA, NCF1, NCF4, ITK, TXK | More | | Antipyrine | hsa04713 | Circadian entrainment | 1.75E-02 | 4 | Q13557, Q02153, P61952, P63092 | CAMK2D, GUCY1B3, GNG11, GNAS | More | | Antipyrine | hsa04720 | Long-term potentiation | 1.38E-02 | 3 | P16298, P51812, Q02750 | PPP3CB, RPS6KA3, MAP2K1 | More | | Antipyrine | hsa04722 | Neurotrophin signaling pathway | 2.83E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | | Antipyrine | hsa04728 | Dopaminergic synapse | 1.07E-04 | 9 | P63092, P61952, P31751, Q99941, Q13557, Q13362, Q14738, P0DP23, O15516 | GNAS, GNG11, AKT2, CREBL1, CAMK2D, PPP2R5C, PPP2R5D, CALM1, CLOCK | More | | Antipyrine | hsa04740 | Olfactory transduction | 2.41E-02 | 1 | P0DP23 | CALM1 | More | | Antipyrine | hsa04744 | Phototransduction | 1.81E-02 | 1 | P0DP23 | CALM1 | More | | Antipyrine | hsa04910 | Insulin signaling pathway | 9.82E-04 | 2 | P0DP23, P31751 | CALM1, AKT2 | More | | Antipyrine | hsa04911 | Insulin secretion | 4.88E-02 | 3 | P63092, Q99941, Q13557 | GNAS, CREBL1, CAMK2D | More | | Antipyrine | hsa04914 | Progesterone-mediated oocyte maturation | 2.94E-02 | 3 | Q17RY0, P51812, Q02750 | CPEB4, RPS6KA3, MAP2K1 | More | | Antipyrine | hsa04915 | Estrogen signaling pathway | 5.07E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | | Antipyrine | hsa04916 | Melanogenesis | 4.78E-02 | 1 | P0DP23 | CALM1 | More | | Antipyrine | hsa04917 | Prolactin signaling pathway | 2.41E-02 | 1 | P31751 | AKT2 | More | | Antipyrine | hsa04920 | Adipocytokine signaling pathway | 1.22E-02 | 5 | P25963, P33121, Q04759, P31751, P01375 | NFKBIA, ACSL1, PRKCQ, AKT2, TNF | More | | Antipyrine | hsa04921 | Oxytocin signaling pathway | 3.13E-02 | 3 | P0DP23, Q96RR4, Q13469 | CALM1, CAMKK2, NFATC2 | More | | Antipyrine | hsa04922 | Glucagon signaling pathway | 1.79E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | | Antipyrine | hsa04923 | Regulation of lipolysis in adipocytes | 3.01E-02 | 1 | P31751 | AKT2 | More | | Antipyrine | hsa04924 | Renin secretion | 3.01E-02 | 1 | P0DP23 | CALM1 | More | | Antipyrine | hsa04929 | GnRH secretion | 1.81E-02 | 1 | P31751 | AKT2 | More | | Antipyrine | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 3.21E-02 | 5 | P84022, Q13485, P42338, P49767, P19174 | SMAD3, SMAD4, PIK3CB, VEGFC, PLCG1 | More | | Antipyrine | hsa04934 | Cushing syndrome | 1.75E-02 | 4 | Q99941, P63092, O15169, Q13557 | CREBL1, GNAS, AXIN1, CAMK2D | More | | Antipyrine | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | | Antipyrine | hsa04966 | Collecting duct acid secretion | 4.93E-02 | 1 | P00918 | CA2 | More | | Antipyrine | hsa04970 | Salivary secretion | 1.22E-02 | 5 | P22694, Q14643, P17252, P0DP23, P49913 | PRKACB, ITPR1, PRKCA, CALM1, CAMP | More | | Antipyrine | hsa04971 | Gastric acid secretion | 4.78E-02 | 1 | P0DP23 | CALM1 | More | | Antipyrine | hsa04972 | Pancreatic secretion | 1.31E-02 | 2 | Q08828, P62491 | ADCY1, RAB11A | More | | Antipyrine | hsa04973 | Carbohydrate digestion and absorption | 2.41E-02 | 1 | P31751 | AKT2 | More | | Antipyrine | hsa04976 | Bile secretion | 3.87E-02 | 3 | O43315, P22694, P08183 | AQP9, PRKACB, ABCB1 | More | | Antipyrine | hsa04979 | Cholesterol metabolism | 1.61E-02 | 2 | P38571, P61916 | LIPA, NPC2 | More | | Antipyrine | hsa05010 | Alzheimer disease | 2.44E-05 | 11 | Q00535, P0DP23, P04406, P18848, Q71U36, Q13885, P67870, P31751, P05141, P12236, P43686 | CDK5, CALM1, GAPDH, ATF4, TUBA1A, TUBB2A, CSNK2B, AKT2, SLC25A5, SLC25A6, PSMC4 | More | | Antipyrine | hsa05012 | Parkinson disease | 8.59E-03 | 6 | P05141, P12236, P18848, P43686, Q71U36, Q13885 | SLC25A5, SLC25A6, ATF4, PSMC4, TUBA1A, TUBB2A | More | | Antipyrine | hsa05014 | Amyotrophic lateral sclerosis | 2.47E-02 | 6 | P20333, P18848, Q71U36, Q13885, P43686, P51991 | TNFRSF1B, ATF4, TUBA1A, TUBB2A, PSMC4, HNRPA3 | More | | Antipyrine | hsa05016 | Huntington disease | 1.30E-03 | 8 | Q9GZM3, P52435, P05141, P12236, Q71U36, Q13885, P43686, P55036 | POLR2J2, POLR2J, SLC25A5, SLC25A6, TUBA1A, TUBB2A, PSMC4, PSMD4 | More | | Antipyrine | hsa05020 | Prion disease | 5.51E-03 | 7 | P18848, P05141, P12236, P43686, Q71U36, Q13885, P67870 | ATF4, SLC25A5, SLC25A6, PSMC4, TUBA1A, TUBB2A, CSNK2B | More | | Antipyrine | hsa05022 | Pathways of neurodegeneration - multiple diseases | 6.47E-04 | 10 | Q71U36, Q13885, P67870, P18848, P05141, P12236, P20333, Q00535, P0DP23, P43686 | TUBA1A, TUBB2A, CSNK2B, ATF4, SLC25A5, SLC25A6, TNFRSF1B, CDK5, CALM1, PSMC4 | More | | Antipyrine | hsa05030 | Cocaine addiction | 4.19E-02 | 1 | Q00535 | CDK5 | More | | Antipyrine | hsa05031 | Amphetamine addiction | 1.00E-02 | 4 | P0DP23, Q13557, P63092, Q99941 | CALM1, CAMK2D, GNAS, CREBL1 | More | | Antipyrine | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 3.87E-02 | 4 | Q16539, P09341, P25024, P25025 | MAPK14, CXCL1, CXCR1, CXCR2 | More | | Antipyrine | hsa05130 | Pathogenic Escherichia coli infection | 1.11E-02 | 5 | Q71U36, P19338, Q13885, P04406, P23396 | TUBA1A, NCL, TUBB2A, GAPDH, RPS3 | More | | Antipyrine | hsa05131 | Shigellosis | 3.34E-02 | 11 | P01375, P25963, O00463, Q04759, Q9UDY8, Q9H1Y0, Q14643, Q12778, Q13315, P10415, Q96A32 | TNF, NFKBIA, TRAF5, PRKCQ, MALT1, ATG5, ITPR1, FOXO1, ATM, BCL2, MYLPF | More | | Antipyrine | hsa05132 | Salmonella infection | 5.49E-03 | 16 | P51617, P25963, P01375, P23396, Q9UJU2, Q13489, P10415, P04406, Q96A32, O60603, Q9BQS8, Q8IWE5, Q13561, Q71U36, Q13509, Q13885 | IRAK1, NFKBIA, TNF, RPS3, LEF1, BIRC3, BCL2, GAPDH, MYLPF, TLR2, FYCO1, PLEKHM2, DCTN2, TUBA1A, TUBB3, TUBB2A | More | | Antipyrine | hsa05133 | Pertussis | 2.64E-03 | 2 | P0DP23, P0C0L4 | CALM1, C4A | More | | Antipyrine | hsa05140 | Leishmaniasis | 1.59E-03 | 9 | O75015, P14598, P13765, O60603, P25963, P01375, Q16539, P51617, Q15080 | FCGR3B, NCF1, HLA-DOB, TLR2, NFKBIA, TNF, MAPK14, IRAK1, NCF4 | More | | Antipyrine | hsa05143 | African trypanosomiasis | 1.74E-03 | 2 | P69905, P68871 | HBA2, HBB | More | | Antipyrine | hsa05144 | Malaria | 1.16E-04 | 7 | P60033, P69905, P68871, O60603, P01375, P35443, P26718 | CD81, HBA2, HBB, TLR2, TNF, THBS4, KLRK1 | More | | Antipyrine | hsa05145 | Toxoplasmosis | 3.07E-02 | 7 | P51617, P25963, P01375, P10415, Q13489, P13765, O60603 | IRAK1, NFKBIA, TNF, BCL2, BIRC3, HLA-DOB, TLR2 | More | | Antipyrine | hsa05146 | Amoebiasis | 9.31E-04 | 8 | P09341, P14778, P27930, P01375, O60603, P05089, P22694, P08311 | CXCL1, IL1R1, IL1R2, TNF, TLR2, ARG1, PRKACB, CTSG | More | | Antipyrine | hsa05152 | Tuberculosis | 7.36E-03 | 11 | Q13488, P0DP23, P48382, O60603, P01375, P31751, P10415, P13765, P49913, Q9UDY8, P51617 | TCIRG1, CALM1, RFX5, TLR2, TNF, AKT2, BCL2, HLA-DOB, CAMP, MALT1, IRAK1 | More | | Antipyrine | hsa05161 | Hepatitis B | 2.33E-02 | 8 | P17252, P14780, P25963, P01375, P10415, P51617, O60603, Q14765 | PRKCA, MMP9, NFKBIA, TNF, BCL2, IRAK1, TLR2, STAT4 | More | | Antipyrine | hsa05163 | Human cytomegalovirus infection | 8.39E-03 | 8 | P31751, P01375, P0DP23, P49841, P14778, P25025, Q16539, O00463 | AKT2, TNF, CALM1, GSK3B, IL1R1, CXCR2, MAPK14, TRAF5 | More | | Antipyrine | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 1.44E-04 | 8 | P31751, P23458, P62879, Q13469, P16298, Q02750, P0DP23, P0CG47 | AKT2, JAK1, GNB2, NFATC2, PPP3CB, MAP2K1, CALM1, UBB | More | | Antipyrine | hsa05169 | Epstein-Barr virus infection | 4.41E-02 | 8 | P13765, Q13547, O00463, Q16539, P24522, O60603, P09693, P20963 | HLA-DOB, HDAC1, TRAF5, MAPK14, GADD45A, TLR2, CD3G, CD247 | More | | Antipyrine | hsa05170 | Human immunodeficiency virus 1 infection | 2.86E-07 | 23 | P31751, Q02750, P01889, P10321, P62879, P16298, P0DP23, P01375, Q05397, P17252, O00463, Q14643, P51617, P25963, O60603, Q13315, O95067, Q9NQU5, P10415, Q13619, Q93034, Q9Y6Q5, P20333 | AKT2, MAP2K1, HLA-B, HLA-C, GNB2, PPP3CB, CALM1, TNF, PTK2, PRKCA, TRAF5, ITPR1, IRAK1, NFKBIA, TLR2, ATM, CCNB2, PAK6, BCL2, CUL4A, CUL5, AP1M2, TNFRSF1B | More | | Antipyrine | hsa05200 | Pathways in cancer | 1.81E-03 | 19 | Q13751, P42338, P08238, P19174, P43246, P84022, Q13485, Q13547, P30281, P49767, P31751, P43657, P63218, P50151, Q14344, Q7LDG7, O75293, P0DP23, P14784 | LAMB3, PIK3CB, HSP90AB1, PLCG1, MSH2, SMAD3, SMAD4, HDAC1, CCND3, VEGFC, AKT2, P2RY5, GNG5, GNG10, GNA13, RASGRP2, GADD45B, CALM1, IL2RB | More | | Antipyrine | hsa05202 | Transcriptional misregulation in cancer | 7.86E-06 | 17 | Q12778, Q15532, Q13315, P41732, P14780, P27930, P14923, Q16548, Q13489, Q13077, O15550, P35226, P05164, P12838, P08246, Q9C0K0, P24522 | FOXO1, SS18, ATM, TSPAN7, MMP9, IL1R2, JUP, BCL2A1, BIRC3, TRAF1, UTX, BMI1, MPO, DEFA4, ELA2, BCL11B, GADD45A | More | | Antipyrine | hsa05211 | Renal cell carcinoma | 4.78E-02 | 1 | P31751 | AKT2 | More | | Antipyrine | hsa05212 | Pancreatic cancer | 1.26E-03 | 7 | P42338, P31751, Q15311, P23458, P84022, Q13485, O75293 | PIK3CB, AKT2, RALBP1, JAK1, SMAD3, SMAD4, GADD45B | More | | Antipyrine | hsa05213 | Endometrial cancer | 4.72E-03 | 3 | O15169, P31751, Q02750 | AXIN1, AKT2, MAP2K1 | More | | Antipyrine | hsa05214 | Glioma | 5.75E-04 | 2 | P0DP23, P31751 | CALM1, AKT2 | More | | Antipyrine | hsa05218 | Melanoma | 3.01E-02 | 1 | P31751 | AKT2 | More | | Antipyrine | hsa05220 | Chronic myeloid leukemia | 3.64E-03 | 6 | Q13547, Q13485, P84022, P31751, P42338, O75293 | HDAC1, SMAD4, SMAD3, AKT2, PIK3CB, GADD45B | More | | Antipyrine | hsa05221 | Acute myeloid leukemia | 4.19E-02 | 1 | P31751 | AKT2 | More | | Antipyrine | hsa05222 | Small cell lung cancer | 5.10E-03 | 7 | P31751, Q13489, P10415, P25963, Q13077, O00463, P24522 | AKT2, BIRC3, BCL2, NFKBIA, TRAF1, TRAF5, GADD45A | More | | Antipyrine | hsa05223 | Non-small cell lung cancer | 2.41E-02 | 1 | P31751 | AKT2 | More | | Antipyrine | hsa05226 | Gastric cancer | 4.72E-03 | 3 | Q02750, P31751, O15169 | MAP2K1, AKT2, AXIN1 | More | | Antipyrine | hsa05230 | Central carbon metabolism in cancer | 4.78E-02 | 1 | P31751 | AKT2 | More | | Antipyrine | hsa05231 | Choline metabolism in cancer | 2.60E-02 | 3 | Q9Y259, P19174, P49619 | CHKB, PLCG1, DGKG | More | | Antipyrine | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 4.03E-02 | 5 | P20963, P09693, P06239, O60603, Q16539 | CD247, CD3G, LCK, TLR2, MAPK14 | More | | Antipyrine | hsa05310 | Asthma | 3.88E-02 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Antipyrine | hsa05321 | Inflammatory bowel disease | 1.28E-02 | 5 | O60603, P01375, P13765, Q14765, P23771 | TLR2, TNF, HLA-DOB, STAT4, GATA3 | More | | Antipyrine | hsa05322 | Systemic lupus erythematosus | 4.20E-02 | 7 | P08246, P08311, P01375, P10747, P13765, Q6FI13, P05455 | ELA2, CTSG, TNF, CD28, HLA-DOB, H2AC18; H2AC19, SSB | More | | Antipyrine | hsa05332 | Graft-versus-host disease | 9.30E-03 | 5 | P13765, P10747, P01375, P26715, Q13241 | HLA-DOB, CD28, TNF, KLRC1, KLRD1 | More | | Antipyrine | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.93E-02 | 1 | P54284 | CACNB3 | More | | Antipyrine | hsa05416 | Viral myocarditis | 2.30E-02 | 2 | P10747, P63261 | CD28, ACTG1 | More | | Antipyrine | hsa05418 | Fluid shear stress and atherosclerosis | 3.33E-05 | 9 | Q16539, P31751, Q14145, P10599, P14780, P01375, P14778, P27930, P0DP23 | MAPK14, AKT2, KEAP1, TXN, MMP9, TNF, IL1R1, IL1R2, CALM1 | More | | |